EXOZ
EXOZ
US4618741098
eXoZymes Inc.
Loading chart...

Company Profile

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Latest News

Related stocks

ALT
ALT • United States
Altimmune, Inc.
2.61 USD
507.69M USD 1Y -33.8%
ALLO
ALLO • United States
Allogene Therapeutics, Inc.
1.46 USD
504.42M USD 1Y -4.8%
CTNM
CTNM • United States
Contineum Therapeutics, Inc.
13.38 USD
503.37M USD 1Y +8.4%
RGNX
RGNX • United States
REGENXBIO Inc.
8.07 USD
532.73M USD 1Y -33.8%
PBYI
PBYI • United States
Puma Biotechnology Inc
10.29 USD
531.17M USD 1Y +90.6%
MNPR
MNPR • United States
Monopar Therapeutics Inc.
78.96 USD
529.99M USD 1Y -14.8%
NGNE
NGNE • United States
Neurogene Inc.
26.4 USD
528.3M USD 1Y +2.6%
DRUG.CN
DRUG.CN • United States
BrightMindsBio
77.1 CAD
533.55M USD 1Y -10.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Micro Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende